ENO2 and lymphoma: A broad panel of immunohistochemistry excluded lymphoma and nephroblastoma, confirming extra-adrenal paraganglioma based on strong positivity for anti-synaptophysin, neuron-specific enolase, chromogranin A, and cytokeratin 19 antibodies.